Navigation Links
Pernix Therapeutics Introduces Omeclamox-Pak®, First Product in Gastroenterology Portfolio
Date:5/15/2012

THE WOODLANDS, Texas, May 15, 2012 /PRNewswire/ -- Pernix Therapeutics Holdings, Inc. (NYSE Amex: PTX), a specialty pharmaceutical company, today announced the introduction of Omeclamox-Pak®, a ten-day therapy of omeprazole delayed-release capsules (20 mg), clarithromycin tablets (500 mg) and amoxicillin capsules (500 mg) for the treatment of Helicobacter pylori (H. pylori) infection and duodenal ulcer disease (active or one-year history) to eradicate H. pylori in adult patients.   

Cooper Collins, President and Chief Executive Officer of Pernix Therapeutics, said, "The introduction of Omeclamox-Pak is an important milestone for Pernix as the company's prescription portfolio continues to broaden with the addition of a new branded product that will be launched by our newly established gastroenterology sales force. We are pleased to offer patients suffering from H. pylori infection and duodenal ulcers with a new treatment option that we expect will be available by prescription in July 2012."

Omeclamox-Pak® is a triple combination medication taken orally to treat Helicobacter pylori infection and eradicate duodenal ulcer disease in adults. Treatment consists of the protein pump inhibitor omeprazole and two broad spectrum antibiotics; clarithromycin tablets and amoxicillin capsules. The medications are to be taken together, twice daily, for ten days. 

"We have recruited a new sales force and established a targeted marketing program that will reach gastroenterology professionals in the coming months," said Chuck Hrushka, Vice President of Sales and Marketing at Pernix Therapeutics. "We anticipate physicians and their patients will welcome the short, 10-day dosing regimen, especially when compared to other treatments."

About Omeclamox-Pak®
Omeprazole is an antisecretory drug, wh
'/>"/>

SOURCE Pernix Therapeutics Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Particle Sciences and Pernix Therapeutics Enter into an Agreement to Develop a Pediatric Dermatology Product
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
4. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
5. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
6. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
7. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
8. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
9. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
10. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
11. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... 3, 2015  GenVec, Inc. (NASDAQ: GNVC ) ... T. Curiel and his team from the School ... Louis (WUSTL).  Dr. Curiel is the director ... Division within the Department of Radiation Oncology. ... will create modified versions of GenVec,s gorilla adenovectors that ...
(Date:6/3/2015)... Research and Markets ( http://www.researchandmarkets.com/research/ssvbft/europe_ultrasound ) has announced the ... Growth, Trends And Forecasts (2014 - 2019)" report ... is dominated by the likes of UK followed by ... Germany . This can be attributed ... regions. The European Ultrasound devices market can ...
(Date:6/2/2015)... 2015  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ... commercialization of products for the treatment of central nervous ... , M.D., Vanda,s President and CEO, will deliver a ... New York City on Thursday, ... The presentation at the Jefferies Global Healthcare Conference ...
Breaking Medicine Technology:GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines 2GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines 3GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines 4European Ultrasound Devices Market Report 2015-2019 2
... DIEGO, Calif., May 18, 2012  Not all discount dental ... and CEO at First Dental Health . Unexpected fees ... by surprise. In addition, some discount dental plan specialists, fee ... all plans are licensed in the states where they operate. ...
... 2012  Receptos Inc. today announced that company personnel will ... Digestive Disease Week (DDW) annual meeting at 9 a.m. ... Diego Convention Center in San Diego, California. DDW attracts ... world to share the latest research in gastrointestinal health ...
Cached Medicine Technology:Consumers Are Advised to Be Aware of Hidden Costs in Some Discount Dental Plans 2Receptos to Deliver Scientific Presentation at Digestive Disease Week 2012 about the Therapeutic Role of RPC1063 in Inflammatory Bowel Disease 2
(Date:6/3/2015)... June 03, 2015 Justina Molzon, MS ... Award at DIA’s upcoming Annual Meeting. DIA’s Global Inspire ... leadership, level of excellence, and commitment to service on ... the Excellence in Service Award that recognizes the “Member ... a DIA volunteer and who has contributed to the ...
(Date:6/3/2015)... 2015 Z-Medica®, LLC, a leading developer ... has been designated as National Safety Month by the ... Police Department for its commitment to public safety. ... Individual First Aid Kits (IFAK) over 100 times in ... stabbings or traffic accidents. Each kit is equipped with ...
(Date:6/3/2015)... The panel of independent experts has spent weeks ... for the awards presented tonight at TU-Automotive Detroit 2015. ... the best-of-the-best can now be revealed as: , Car ... swept rivals aside by taking the coveted Car Maker ... our panel of expert judges., Stand out comments included: ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 For the fourth ... ( http://myclassifiedads.net ), a full-service advertising agency, has been honored ... Chamber of Commerce. , MCA has been selected as a ... The company will be honored at a luncheon sponsored by ... the Tampa Museum of Art. , “This luncheon will include ...
(Date:6/3/2015)... TN (PRWEB) June 03, 2015 According ... Inquisitr police officers intercepted fake oxycodone pills which ... pills were doctored to look legitimate, and even sported ... officers are warning those consuming 30 mg oxycodone to ... the pills online or buy them illegally on the ...
Breaking Medicine News(10 mins):Health News:Former FDA Official and U.S. Public Health Service Officer to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 2Health News:Former FDA Official and U.S. Public Health Service Officer to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 3Health News:Z-Medica Commends Tucson Police Department for Trauma Kit Utilization 2Health News:TU-Automotive Awards 2015 winners revealed 2Health News:TU-Automotive Awards 2015 winners revealed 3Health News:My Classified Ads Has Been Selected as a Semi-Finalist for the 2015 ‘Small Business of the Year’ Awards 2Health News:My Classified Ads Has Been Selected as a Semi-Finalist for the 2015 ‘Small Business of the Year’ Awards 3Health News:Fake Oxycodone Pills of Fentanyl Discovered in Tennessee by Police 2Health News:Fake Oxycodone Pills of Fentanyl Discovered in Tennessee by Police 3
... in ovarian cancer has provided the most comprehensive and integrated ... Ovarian serous adenocarcinoma tumors from 500 patients were examined by ... reported in the June 30, 2011, issue of Nature ... of ovarian cancer, accounting for about 85 percent of all ...
... (HealthDay News) -- Obesity is a major risk factor ... women, a new study finds. It included more than ... smoked and were followed for 28 years. During that time, ... disease and 487 (27 percent) from cancer. Researchers found ...
... recent study accepted for publication in The Endocrine Society,s ... early, prolonged treatment with the diabetes drug metformin may prevent ... adolescence. PCOS affects 7 to 10 percent of ... of infertility, affecting an estimated 5 to 6 million women ...
... Reporter , TUESDAY, June 28 (HealthDay News) -- A vaccine ... some promise, while another designed to alter insulin production fails, ... results of both studies were slated to be presented Tuesday ... Type 1 diabetes often appears early in life and ...
... are teaming up to offer one of the nation,s ... trucks. Led by the University of Maryland and ... program will target the so-called short-haul "drayage" fleet that ... The effort seeks to double the impact ...
... TUESDAY, June 28 (HealthDay News) -- Mammography screening reduces breast ... according to a new, large-scale Swedish trial. In a ... longest ever -- the researchers found that the benefits of ... In fact, most of the benefits occur more than 10 ...
Cached Medicine News:Health News:The Cancer Genome Atlas completes detailed ovarian cancer analysis 2Health News:The Cancer Genome Atlas completes detailed ovarian cancer analysis 3Health News:Obesity a Major Cause of Early Death in Women: Study 2Health News:Diabetes drug may prevent or delay development of polycystic ovary syndrome 2Health News:Trials of Type 1 Diabetes Vaccines Bring Mixed Results 2Health News:Trials of Type 1 Diabetes Vaccines Bring Mixed Results 3Health News:Mid-Atlantic states' unique plan to replace region's dirtiest trucks 2Health News:Mid-Atlantic states' unique plan to replace region's dirtiest trucks 3Health News:Longest Trial Ever Confirms Mammograms' Benefits 2Health News:Longest Trial Ever Confirms Mammograms' Benefits 3
... Instruments incorporate a layered design unique in ... monitored to prevent stray electrosurgical burns along ... insulation failure or capacitive coupling; a well-documented ... into all AEM Instruments provides a neutral ...
... Laparoscopic Instruments incorporate a layered design unique ... and monitored to prevent stray electrosurgical burns ... by insulation failure or capacitive coupling; a ... built into all AEM Instruments provides a ...
... Laparoscopic Instruments incorporate a layered design unique ... and monitored to prevent stray electrosurgical burns ... by insulation failure or capacitive coupling; a ... built into all AEM Instruments provides a ...
... The 5mm AEM Laparoscopic Instruments incorporate ... AEM Instruments are shielded and monitored to ... of the instrument caused by insulation failure ... risk. The protective shield built into all ...
Medicine Products: